Biological Drugs Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Biological Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.

    This report presents the market size and development trends by detailing the Biological Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biological Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biological Drugs industry and will help you to build a panoramic view of the industrial development.

    Biological Drugs Market, By Type:

    • Therapeutic Protein

    • Monoclonal Antibody

    • Vaccine

    Biological Drugs Market, By Application:

    • Hospital

    • Clinics

    • Research Centers

    Some of the leading players are as follows:

    • Pfizer

    • Novartis

    • Biogen

    • Baxter

    • Abbott Laboratories

    • Merck

    • GlaxoSmithKline

    • Eli Lilly and Company

    • Bristol-Myers Squibb Company

    • Amgen

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Biological Drugs Market: Technology Type Analysis

    • 4.1 Biological Drugs Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Biological Drugs Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Therapeutic Protein

      • 4.3.2 Monoclonal Antibody

      • 4.3.3 Vaccine

    5 Biological Drugs Market: Product Analysis

    • 5.1 Biological Drugs Product Market Share Analysis, 2018 & 2026

    • 5.2 Biological Drugs Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Biological Drugs Market: Application Analysis

    • 6.1 Biological Drugs Application Market Share Analysis, 2018 & 2026

    • 6.2 Biological Drugs Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Clinics

      • 6.3.3 Research Centers

    7 Biological Drugs Market: Regional Analysis

    • 7.1 Biological Drugs Regional Market Share Analysis, 2018 & 2026

    • 7.2 Biological Drugs Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Pfizer

      • 9.1.1 Pfizer Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Novartis

      • 9.2.1 Novartis Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Biogen

      • 9.3.1 Biogen Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Baxter

      • 9.4.1 Baxter Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Abbott Laboratories

      • 9.5.1 Abbott Laboratories Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Merck

      • 9.6.1 Merck Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 GlaxoSmithKline

      • 9.7.1 GlaxoSmithKline Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Eli Lilly and Company

      • 9.8.1 Eli Lilly and Company Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Bristol-Myers Squibb Company

      • 9.9.1 Bristol-Myers Squibb Company Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Amgen

      • 9.10.1 Amgen Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 107 Figures and 151 Tables)

    • Figure Therapeutic Protein Biological Drugs market, 2015 - 2026 (USD Million)

    • Figure Monoclonal Antibody Biological Drugs market, 2015 - 2026 (USD Million)

    • Figure Vaccine Biological Drugs market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure Research Centers market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Biological Drugs market, by country, 2015 - 2026 (USD Million)

    • Table North America Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table North America Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table North America Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Canada Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Canada Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Europe Biological Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Europe Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Europe Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Europe Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Germany Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Germany Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table France Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table France Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Italy Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Italy Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Spain Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Spain Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table China Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table China Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Japan Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Japan Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table India Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table India Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table MEA Biological Drugs market, by country, 2015 - 2026 (USD Million)

    • Table MEA Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table MEA Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table MEA Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Biological Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Biological Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Biological Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biogen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Baxter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.